Statistics about Multiple Sclerosis
Prevalence and incidence statistics for Multiple Sclerosis:
See also prevalence and incidence page for Multiple Sclerosis
Prevalance of Multiple Sclerosis:
1-in-700 (NIAID)
Prevalance Rate: approx 1 in 700 or 0.14% or 388,571 people in USA [about data]
Prevalance of Multiple Sclerosis:
Multiple
sclerosis afflicts 1 in 700 people in this country. (Source: excerpt from Understanding Autoimmune Disease: NIAID)
Prevelance statistics about Multiple Sclerosis:
The following statistics relate to the prevalence of Multiple Sclerosis:
- 300,000 Americans
- 146,892 people in the USA 1996 1
- 250,000 to 500,000 cases in the US (Multiple Sclerosis Foundation, NIH, 2004)
- Estimated 250,000 to 500,000 Americans (NWHIC)
- more about prevalence...»
Multiple Sclerosis Prevalence: Book Excerpts
Society statistics for Multiple Sclerosis
Hospitalization statistics for Multiple Sclerosis:
The following are statistics from various sources
about hospitalizations and Multiple Sclerosis:
- 0.129% (16,411) of hospital consultant episodes were for multiple sclerosis in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 90% of hospital consultant episodes for multiple sclerosis required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 31% of hospital consultant episodes for multiple sclerosis were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 69% of hospital consultant episodes for multiple sclerosis were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 23% of hospital consultant episodes for multiple sclerosis required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 13.9 days was the mean length of stay in hospitals for multiple sclerosis in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 4 days was the median length of stay in hospitals for multiple sclerosis in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 46 was the mean age of patients hospitalised for multiple sclerosis in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 86% of hospital consultant episodes for multiple sclerosis occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 2% of hospital consultant episodes for multiple sclerosis occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 37% of hospital consultant episodes for multiple sclerosis were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
- 0.199% (104,557) of hospital bed days were for multiple sclerosis in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
About statistics:
This page presents a variety of statistics about Multiple Sclerosis.
The term 'prevalence' of Multiple Sclerosis usually refers to the estimated population
of people who are managing Multiple Sclerosis at any given time.
The term 'incidence' of Multiple Sclerosis refers to the annual diagnosis rate,
or the number of new cases of Multiple Sclerosis diagnosed each year.
Hence, these two statistics types can differ:
a short-lived disease like flu can have high annual incidence but low prevalence,
but a life-long disease like diabetes has a low annual incidence but high prevalence.
For more information see about prevalence and incidence statistics.
The symptoms of multiple sclerosis can be as numerous as they are frustrating. Keeping them under control is a primary focus of MS treatment, and...
If you have MS, you know that you rely heavily on your doctor to keep you in good health. But treatment is your responsibility as well, and that...
Although MS has visible manifestations, many of its symptoms are not outwardly apparent. This is the "invisible" side of MS, which means that in many...
After being suspended from the market for safety reasons, natalizumab is again available for the treatment of multiple sclerosis. Safeguards are in...
See full list of 6 related videos
» Next page: Statistics by Country for Multiple Sclerosis
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards: